Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals

Journal of Virology

Volumn 70, Issue 5, 1996, Pages 3286-3289

  Decker, Lisa L ^a   Klaman, Lori D ^a   Thorley Lawson, David A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; EPISOME; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; NORMAL HUMAN; PRIORITY JOURNAL; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0029947349     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.5.3286-3289.1996     Document Type: Article

References (21)

1. Adams, A. 1979. The state of the virus genome in transformed cells and Its relationship to host cell DNA. p. 156-178. In M. A. Epstein and B. G. Achong (ed.), The Epstein-Barr virus. Springer-Verlag KG, Berlin.
2. Chen, F., J.-Z. Zou, L. Di Renzo, G. Winberg, L.-F. Hu, E. Klein, G. Klein, and I. Ernberg. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69:3752-3758.
3. Efstathiou, S., A. C. Minson, H. J. Field, J. R. Anderson, and P. Wildy. 1986. Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans. J. Virol. 57:446-455.
4. Gardella, T., P. Medveczky, T. Sairenji, and C. Mulder. 1984. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J. Virol. 50:248-254.
5. Hurley, E. A., S. Agger, J. A. McNeil, J. B. Lawrence, A. Calendar, G. Lenoir, and D. A. Thorley-Lawson. 1991. When Epstein-Barr virus persistently in-fects B-cell lines, it frequently integrates. J. Virol. 65:1245-1254.
6. Hurley, E. A., and D. A. Thorley-Lawson. 1988, B cell activation and the establishment of Epstein-Barr virus latency. J. Exp. Med. 168:2059-2075.
7. 6a. Khan, G., et al. Unpublished data
8. Kieff, E., and D. Liebowitz. 1990 Epstein-Barr virus and its replication, p. 1889-1920 In B. N. Fields and D. M. Knipe (ed.). Virology. Raven Press, New York.
9. Klein, G. 1994. Epstein-Barr virus strategy in normal and neoplastic B-cells. Cell 77:791-793.
10. Masucci, M. G., and I. Ernberg. 1994. Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol 2:125-130.
11. Miller, C. L., A. L. Burkhardt J. H. Lee, B. Stealey, R. Longnecker, J. B. Bolen, and E. Kieff. 1995. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases Immunity 2:155-166.
12. Miller, G. 1990. EBV biology, pathogenesis and medical aspects, p. 1921-1958. In B. N. Fields and D. M. Knipe (ed.), Virology. Raven Press, New York.
13. 11a. Miyashita, E. M., et al. Unpublished data.
14. 11b. Miyashita, E. M., and D. A. Thorley-Lawson. Unpublished data.
15. Miyashita, E. M., B. Yang, K. M. Lam, D. H. Crawford, and D. A. Thorley-Lawson. 1995. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593-601.
16. Nonoyama, M., and J. S. Pagano. 1971. Detection of Epstein-Barr viral genome in nonproductive cells. Nature New Biol. 233:103-106.
17. Qu, L., and D. T. Rowe. 1992. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes J. Virol. 66:3715-3724.
18. Schulte, H. H., and H. zur Hausen. 1970. Partial purification of the Epstein-Barr virus and some properties of its DNA. Virology 40:776-779.
19. Thorley-Lawson, D. A., and K. P. Mann. 1985. Early events in Epstein-Barr virus infection provide a model for B cell activation. J. Exp. Med. 162:45-59.
20. Tierney, R. J., N. Steven, L. S. Young, and A. B. Rickinson. 1994. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol 68: 7374-7385.
21. Yao, Q. Y., H. Czarnecka, and A. B. Rickinson. 1991. Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities. Int. J. Cancer 48:253-257.